Closing the GAPS: Guideline Adherence, Prevention and Surveillance in Hereditary Cancer
NCT: NCT06654466 · ACTIVE_NOT_RECRUITING
Brief Summary
The goal of this clinical trial is to see if a software platform can improve cancer screening in young adults with genetic risk for cancer. The trial will also help improve the software platform (Nest). The main questions it aims to answer are: * Do Nest users know more about their cancer risks and recommended care than non-users? * Do Nest users have less psychological distress than non-users? * Do Nest users share cancer risks with family and other doctors more than non-users? * Are Nest users more likely than non-users to have up-to-date care plans? Researchers will compare Nest users to non-users to see if the Nest users are more likely to do recommended cancer screening. Participants will: * Have a genetic counseling or follow up visit * Take a post-visit survey * Intervention arm only: use the Nest Patient Navigator * Complete screening and follow-up care recommended by doctors
Frequently Asked Questions
What is Closing the GAPS: Guideline Adherence, Prevention and Surveillance in Hereditary Cancer?
Closing the GAPS: Guideline Adherence, Prevention and Surveillance in Hereditary Cancer is a clinical trial registered under NCT06654466. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT06654466?
The current status of NCT06654466 (Closing the GAPS: Guideline Adherence, Prevention and Surveillance in Hereditary Cancer) is: ACTIVE_NOT_RECRUITING.
When did Closing the GAPS: Guideline Adherence, Prevention and Surveillance in Hereditary Cancer start?
Closing the GAPS: Guideline Adherence, Prevention and Surveillance in Hereditary Cancer started on 2026-02-10.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.